<DOC>
	<DOCNO>NCT00930293</DOCNO>
	<brief_summary>This study examine feasibility efficacy personalize psychotherapy treatment people depression co-occurring anxiety .</brief_summary>
	<brief_title>Efficacy Feasibility Personalized Treatment Depression With Co-Occurring Anxiety</brief_title>
	<detailed_description>Approximately one half depress psychiatric patient also meet criterion anxiety disorder . Compared people depression , people depression panic feature experience poor psychological social functioning , great risk suicide , less response medication therapy treatment , great risk recur symptom . Because people depression co-occurring anxiety feature achieve full symptom remission either medication therapy alone , study use treatment combine two . A commonly use type depression medication call selective serotonin reuptake inhibitor ( SSRI ) combine specialized therapy develop address depression co-occurring symptom panic , anxiety , avoidance . This study also test computer-based method assess mood anxiety symptom profile outcomes determine whether participant find method acceptable clinician find useful . Participation study last 20 week , follow-up visit occur 4 8 month start . Participants randomly assign receive either individualized therapy depression anxiety , call interpersonal psychotherapy depression panic anxiety symptom ( IPT-PS ) , standard therapy depression , call brief supportive psychotherapy ( BSP ) . All participant complete 16 therapy session receive standard SSRI treatment medication citalopram hydrobromide . During IPT-PS treatment , study therapist examine regular computer update depression anxiety score participant talk identify address life stressor trigger symptom . During BSP treatment , study therapist encourage participant arrive solution emphasize participant ' strength examine work past . Participants complete assessment weekly 20 week study intervention 4- 8-month follow-up visit . These assessment include self-report questionnaire symptom , medication side effect , treatment adherence ; vital sign weight measurement ; clinical interview . Regular assessment medication effectiveness side effect occur every 1 4 week . Starting second study visit , participant also complete monthly computer-based questionnaire depression anxiety symptom .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Currently episode nonpsychotic major depression , define DSMIV document Structured Clinical Interview Axis I , DSMIV Disorders ( SCID ) rating great 15 25item Hamilton Rating Scale Depression ( HRSD ) Panic spectrum risk category least 7 , define PanicAgoraphobic Spectrum SelfReport ( PASSR ) , last month version Not currently receive effective treatment Participants suicidal ideation eligible long outpatient treatment deem safe . History manic hypomanic episode ( ) History schizophrenia schizoaffective disorder Mood disorder due general medical condition induce substance use Presence psychosis Current pregnancy plan become pregnant Current primary diagnosis anorexia nervosa bulimia nervosa ( include eat disorder otherwise specify [ NOS ] ) Current primary diagnosis severe obsessivecompulsive disorder ( OCD ) , determine clinician evaluation symptom severity temporal onset symptom Drug alcohol abuse dependence within past 3 month ( participant episodic abuse relate mood episode exclude ) Satisfies full DSMIV criterion antisocial personality disorder , determine SCIDII evaluation Requires inpatient treatment suicidal risk psychotic symptom ( current suicidal think parasuicidal behavior exclusionary , clinician judgment , manage outpatient basis ) Any follow medical condition : 1 . An index episode secondary effect medically prescribe drug , i.e. , reserpine , antihistamine , etc . 2 . Presence significant uncontrolled medical illness include cardiovascular disorder , kidney liver disease , epilepsy , untreated hypertension , unstabilized endocrine disease ( stable medical condition wellcontrolled diabetes HIV positive status exclusionary provide participant meet inclusion exclusion criterion ) 3 . Current treatment pharmacologic , overthecounter , herbal therapy depression anxiety ( unless participant wish discontinue ineffective treatment ) History poor fail treatment response adequate dose duration citalopram</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Interpersonal Psychotherapy</keyword>
</DOC>